HIGHLIGHTS
- who: Jennifer Yang and colleagues from the Department of Neurology, Clinical Autoimmunity Center of Excellence, Graduate Program in Immunology, Program in Biomedical Sciences, University of Michigan Medical School, Ann Arbor, MI, USA have published the paper: Current and Future Biomarkers in Multiple Sclerosis, in the Journal: Microbiome of 22/03/2022
- what: The overall goal of all DMTs is to dampen the pro-inflammatory response while boosting the anti-inflammatory response by enhancing Th2, Treg, and regulatory B (Breg) cells .
- future: Specifically kappa free light chain has been found to be increased in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.